Bio-Rad Laboratories | BIO - Net Income

Stock Price
287.84
Daily Change
6.42 2.28%
Monthly
5.20%
Yearly
18.77%
Q2 Forecast
281.68

Bio-Rad Laboratories reported $-341.9M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Agilent USD 305M 129M Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Bio Techne USD 38.01M 176K Dec/2025
Bio-Rad Laboratories USD -341.9M 659.7M Sep/2025
Bruker USD 26M 88.4M Dec/2025
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Danaher USD 1.03B 168M Mar/2026
General Electric Aerospace USD 1.9B 637M Mar/2026
Illumina USD 334M 184M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Laboratory Of America USD 164.7M 96.4M Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Mettler Toledo International USD 285.76M 68.27M Dec/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Repligen USD 13.29M 1.62M Dec/2025
Revvity USD 98.36M 51.71M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Siemens EUR 2.03B 411M Dec/2025
Standard Biotools USD 19.28M 53.97M Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Tosoh JPY 17.25B 16.4B Dec/2025
Waters USD 225.21M 76.29M Dec/2025